Vaccinex, Inc.
HUMAN ANTI-SEMAPHORIN 4D ANTIBODY
Last updated:
Abstract:
Compositions and method are provided for treating diseases associated with semaphorin-4D (SEMA4D) pathology, including autoimmune diseases, inflammatory diseases, cancers, neuroinflammatory disorders and neurodegenerative diseases.
Status:
Application
Type:
Utility
Filling date:
4 May 2018
Issue date:
4 Feb 2021